PLAY PODCASTS
Ep. 12: How IBD Called The Correction – And Where It May Go With Chris Gessel
Season 1 · Episode 12

Ep. 12: How IBD Called The Correction – And Where It May Go With Chris Gessel

This is how we spot sell-offs that could be prolonged.

Investing With IBD · Investor's Business Daily

May 30, 201952m 51s

Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

This week, IBD Chief Content Officer Chris Gessel joined the podcast to discuss "vertical violations," which can be used to spot prolonged sell-offs. We also look at three stocks that are bucking the downtrend: Repligen, Anaplan and Insulet. Plus, Randy Watts of William O'Neil + Co. returns for a sponsored interview with Doug Peebles, Chief Investment Officer of Fixed Income at AllianceBernstein, about fixed income strategies. For the video version, show notes and charts, go to investors.com/podcast.

Learn more about your ad choices. Visit megaphone.fm/adchoices